ArticleClinical and translational science2023

Pharmacokinetic/LDL-C and exposure-response analysis of tafolecimab in Chinese hypercholesterolemia patients: Results from phase I, II, and III studies.

Shuling Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.